Key Metrics
CiteScore 

1.5
Impact Factor 

< 5
SJR 

Q4Internal Medicine

SNIP 

0.54
Recommended pre-submission checks
Powered by 

Topics Covered on Sarcoidosis Vasculitis and Diffuse Lung Diseases
Sarcoidosis Vasculitis and Diffuse Lung Diseases Journal Specifications
| Overview | |
| Publisher | MATTIOLI 1885 |
| Language | English |
| Frequency | Quarterly |
| General Details |
View less
Planning to publish in Sarcoidosis Vasculitis and Diffuse Lung Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Sarcoidosis Vasculitis and Diffuse Lung Diseases
Combined use of serum KL-6 and respiratory functional parameters for identifying fibrotic lung damage in SARS-CoV-2-induced interstitial pneumonia.
- 27 Mar 2026
- Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Combination antifibrotic and immunosuppressive therapy in progressive fibrosing ILD.
- 27 Mar 2026
- Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Combined impact of ROR2 and its ligands on the pathogenesis and prognosis of idiopathic pulmonary fibrosis.
- 27 Mar 2026
- Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Intrapulmonary unicentric Castleman's Disease: A clinical analysis of 8 patients.
- 27 Mar 2026
- Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Prognostic significance of incorporating SpO2 recovery time to the 6-minute walk test protocol and to a modified GAP index risk prediction model in patients with idiopathic pulmonary fibrosis.
- 27 Mar 2026
- Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Impact of pulmonary hypertension on mortality in progressive massive fibrosis.
- 27 Mar 2026
- Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Combined use of serum KL-6 and respiratory functional parameters for identifying fibrotic lung damage in SARS-CoV-2-induced interstitial pneumonia.
- 27 Mar 2026
- Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Combination antifibrotic and immunosuppressive therapy in progressive fibrosing ILD.
- 27 Mar 2026
- Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Combined impact of ROR2 and its ligands on the pathogenesis and prognosis of idiopathic pulmonary fibrosis.
- 27 Mar 2026
- Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Intrapulmonary unicentric Castleman's Disease: A clinical analysis of 8 patients.
- 27 Mar 2026
- Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Prognostic significance of incorporating SpO2 recovery time to the 6-minute walk test protocol and to a modified GAP index risk prediction model in patients with idiopathic pulmonary fibrosis.
- 27 Mar 2026
- Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Impact of pulmonary hypertension on mortality in progressive massive fibrosis.
- 27 Mar 2026
- Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG